Dexter X. Jin

2.8k total citations · 1 hit paper
46 papers, 1.5k citations indexed

About

Dexter X. Jin is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dexter X. Jin has authored 46 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 20 papers in Molecular Biology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dexter X. Jin's work include Cancer Genomics and Diagnostics (15 papers), Lung Cancer Treatments and Mutations (7 papers) and DNA Repair Mechanisms (5 papers). Dexter X. Jin is often cited by papers focused on Cancer Genomics and Diagnostics (15 papers), Lung Cancer Treatments and Mutations (7 papers) and DNA Repair Mechanisms (5 papers). Dexter X. Jin collaborates with scholars based in United States, Switzerland and France. Dexter X. Jin's co-authors include Ethan S. Sokol, Piyush B. Gupta, Yuxiong Feng, Ferenc Reinhardt, Jeffrey S. Ross, Alexa B. Schrock, Siraj M. Ali, Idoroenyi Amanam, Samuel J. Klempner and Jaideep Sandhu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Dexter X. Jin

46 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer

2019 441 citations Alexa B. Schrock, Ching Ouyang et al. Annals of Oncology profile →

Peers

Dexter X. Jin

ONCOL

PRM

PFM

Élodie Vauléon France

Omar Kabbarah United States

Dai Shimizu Japan

Raija Ristamäki Finland

Katherine E. Hutchinson United States

Debyani Chakravarty United States

Selma Pennacchietti Italy

Naoki Takahashi Japan

Ophélia Maertens United States

Luigi Formisano Italy

Élodie Vauléon France

Dexter X. Jin

596 ×0.8

ONCOL

522 ×0.9

302 ×0.7

414 ×1.1

PRM

151 ×0.5

PFM

Citations per year, relative to Dexter X. Jin Dexter X. Jin (= 1×) peers Élodie Vauléon

Countries citing papers authored by Dexter X. Jin

Since Specialization

Citations

This map shows the geographic impact of Dexter X. Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dexter X. Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dexter X. Jin more than expected).

Fields of papers citing papers by Dexter X. Jin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dexter X. Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dexter X. Jin. The network helps show where Dexter X. Jin may publish in the future.

Co-authorship network of co-authors of Dexter X. Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Dexter X. Jin. A scholar is included among the top collaborators of Dexter X. Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dexter X. Jin. Dexter X. Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Madison, Russell W., Zoe J. Assaf, Alexander D. Fine, et al.. (2025). Real-World Validity of Tissue-Agnostic Circulating Tumor DNA Response Monitoring in Lung Cancers Treated With Chemotherapy, Immunotherapy, or Targeted Agents. JTO Clinical and Research Reports. 6(9). 100829–100829. 1 indexed citations

Song, K S, Christy C. Ong, Jeff Lau, et al.. (2025). KRAS Codon-Specific Mutations Differentially Toggle PI3K Pathway Signaling and Alter Sensitivity to Inavolisib (GDC-0077). Molecular Cancer Therapeutics. 24(12). 1890–1901. 1 indexed citations

Wijetunga, N. Ari, Krishna Kanchi, Jay A. Moore, et al.. (2024). Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features. Cancer Research Communications. 4(9). 2320–2334. 3 indexed citations

Clark, Allison, Mehrad Tavallai, Dexter X. Jin, et al.. (2024). Genomic profiling and comparative analysis of male versus female metastatic breast cancer across subtypes. Breast Cancer Research. 26(1). 118–118. 2 indexed citations

Sivakumar, Smruthy, Dexter X. Jin, Jeffrey S. Ross, et al.. (2023). Genetic Heterogeneity and Tissue-specific Patterns of Tumors with Multiple PIK3CA Mutations. Clinical Cancer Research. 29(6). 1125–1136. 16 indexed citations

Moore, Jay A., Russell W. Madison, Justin Y. Newberg, et al.. (2023). Pan-Cancer Analysis of Copy-Number Features Identifies Recurrent Signatures and a Homologous Recombination Deficiency Biomarker to Predict Poly (ADP-Ribose) Polymerase Inhibitor Response. JCO Precision Oncology. 7(7). e2300093–e2300093. 13 indexed citations

Batalini, Felipe, Russell W. Madison, Ethan S. Sokol, et al.. (2023). Homologous Recombination Deficiency Landscape of Breast Cancers and Real-World Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Patients With Somatic BRCA1/2, Germline PALB2, or Homologous Recombination Deficiency Signature. JCO Precision Oncology. 7(7). e2300091–e2300091. 8 indexed citations

Sharaf, Radwa, Dexter X. Jin, John P. Grady, et al.. (2023). A pan-sarcoma landscape of telomeric content shows that alterations in RAD51B and GID4 are associated with higher telomeric content. npj Genomic Medicine. 8(1). 26–26. 5 indexed citations

Westphalen, C. Benedikt, Chantal Pauli, Nasséra Chalabi, et al.. (2023). Baseline mutational profiles of patients with carcinoma of unknown primary origin enrolled in the CUPISCO study. ESMO Open. 8(6). 102035–102035. 7 indexed citations

10.

Madison, Russell W., Jay A. Moore, Dexter X. Jin, et al.. (2023). A Novel HRD Signature Is Predictive of FOLFIRINOX Benefit in Metastatic Pancreatic Cancer. The Oncologist. 28(8). 691–698. 11 indexed citations

11.

Jin, Dexter X., Sherri Z. Millis, Aik Choon Tan, et al.. (2023). Gene partners of the EWSR1 fusion may represent molecularly distinct entities. Translational Oncology. 38. 101795–101795. 6 indexed citations

12.

Sivakumar, Smruthy, Dexter X. Jin, Hanna Tukachinsky, et al.. (2022). Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer. Nature Communications. 13(1). 7495–7495. 26 indexed citations

13.

Morfouace, Marie, Vassilis Golfinopoulos, Dexter X. Jin, et al.. (2020). First results of the EORTC-SPECTA/Arcagen study exploring the genomics of rare cancers in collaboration with the European reference network EURACAN. ESMO Open. 5(6). e001075–e001075. 13 indexed citations

14.

Elman, Jessica S., Kristen E. Mengwasser, Dexter X. Jin, et al.. (2019). Identification of FUBP1 as a Long Tail Cancer Driver and Widespread Regulator of Tumor Suppressor and Oncogene Alternative Splicing. Cell Reports. 28(13). 3435–3449.e5. 25 indexed citations

15.

Zhou, Wenhui, Jerrica L. Breindel, Jian Ouyang, et al.. (2019). Loss of Slug Compromises DNA Damage Repair and Accelerates Stem Cell Aging in Mammary Epithelium. Cell Reports. 28(2). 394–407.e6. 34 indexed citations

16.

Schrock, Alexa B., Ching Ouyang, Jaideep Sandhu, et al.. (2019). Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer. Annals of Oncology. 30(7). 1096–1103. 441 indexed citations breakdown →

17.

Miller, Daniel, et al.. (2018). BCL11B Drives Human Mammary Stem Cell Self-Renewal In Vitro by Inhibiting Basal Differentiation. Stem Cell Reports. 10(3). 1131–1145. 10 indexed citations

18.

Feng, Yuxiong, Dexter X. Jin, Ethan S. Sokol, et al.. (2017). Cancer-specific PERK signaling drives invasion and metastasis through CREB3L1. Nature Communications. 8(1). 1079–1079. 106 indexed citations

19.

Sokol, Ethan S., et al.. (2015). Perturbation-Expression Analysis Identifies RUNX1 as a Regulator of Human Mammary Stem Cell Differentiation. PLoS Computational Biology. 11(4). e1004161–e1004161. 20 indexed citations

20.

Feng, Yuxiong, Ethan S. Sokol, Catherine Del Vecchio Fitz, et al.. (2014). Epithelial-to-Mesenchymal Transition Activates PERK–eIF2α and Sensitizes Cells to Endoplasmic Reticulum Stress. Cancer Discovery. 4(6). 702–715. 240 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact